Early Stage 10: The nuances of federal laws ( y upon if a business can be certain tha...)

Early Stage 10: The nuances of federal laws

y upon if a business can be certain that it will not need to raise additional capital shortly after the first offering. If an offering of securities made in reliance on any of the Regulation D rules occurs within six months of another offering, it will be considered integrated - or combined - with the other offering.

This means that if the total raised in two integrated offerings excee......

Full article >>>

Source:wistechnology.com By Joe Boucher 05/04/07

Page: 1 2 3 4 5
Related biology technology :

1. Early Stage: Step 11 - Other forms of finance
2. Early Stage, Step 9: Raising capital in the securities landscape
3. Early Stage, Step 8: Misclassifying workers brings risk
4. Early Stage 7, Part I: Just what is an employee?
5. Early Stage: Step 6 - Taxes, taxes, taxes!
6. Early Stage: Step 5 - Forming the entity
7. Early Stage, Step 4: Cautionary trademark tales
8. Early Stage, Step 3: Naming the entity
9. Early-stage quality brings investment, Meier says
10. Early-stage executives hear from investors
11. Early Stage Step 2: Choosing a domain name

Post Your Comments:

(Date:11/6/2009)...VALLEY, Calif., Nov. 6 Calbiotech,...mall Business Innovative Research (SBIR) Phase I c...rial command. Under terms of the agreement, Calbio... for the diagnosis of Dengue virus. ,, Dengu...nts a major threat to military forces deployed to ...

(Date:11/5/2009)...SBURG, Md., Nov. 5 GenVe...cial results for the third quarter ended September...ion ($0.04 per share) for the three months ended S...illion ($0.08 per share) in the comparable quarter...2009, GenVec,s net loss was $14.1 million ($0.15 p...

(Date:11/5/2009)...nce Call on Thursday, November 5, 2009 at 4:30 p.m...v. 5 /PRNewswire-FirstCall/ - OncoGenex Pharmaceut...: OGXI ) today reported unaudited financial resul...tember 30, 2009 and reviewed the Company,s highlig...wing consolidated results reflect the operations o...

(Date:11/5/2009)...GO, CA, November 5, 2009 ... on using proprietary taste receptor-based technol... food, beverage, and ingredient supply industries,...nancial results for the third quarter ended Septem...third quarter of 2009, compared to $4.0 million fo...

[0] Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus [0] GenVec Reports Third Quarter 2009 Financial Results [0] OncoGenex Reports Third Quarter 2009 Financial Results [0] SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS

...er 23 GlaxoSmithKline Biologicals,S.A. (GSK) and ...llaboration agreement granting GSK exclusive right...mes, aimed at treating Alzheimer,s by,targeting be...iring exclusive rights to develop,and commercialis...are based,on AFFiRiS AFFiTOPE technology and are c...

.... 23 CV Therapeutics,Inc. (Nasdaq: CVTX ) today ...cial results for 2008 after the market closes on T...webcast a conference call at 5:00 p.m. EST,2:00 p....live webcast, please log on to the Company,s websi...Information section. Alternatively,domestic caller...

...l April 27, 2009 to Regain Compliance with $1.00 ...USTIN, Calif., Oct. 23 Peregrine,Pharmaceuticals,...ceutical,company developing monoclonal antibodies ...ctions, today announced that it has received a let...ional time to regain,compliance with the minimum b...

Other Biology Technology:GlaxoSmithKline and AFFiRiS Sign an Exclusive Licence and Option Agreement for Therapeutic Alzheimer's Disease Candidate Vaccines 2 GlaxoSmithKline and AFFiRiS Sign an Exclusive Licence and Option Agreement for Therapeutic Alzheimer's Disease Candidate Vaccines 3 CV Therapeutics to Announce 2008 Third Quarter Financial Results on Thursday, November 6, 2008 2 Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQ's Minimum Bid Price Rule 2

GlaxoSmithKline and AFFiRiS Sign an Exclusive Licence and Option Agreement for Therapeutic Alzheimer's Disease Candidate Vaccines CV Therapeutics to Announce 2008 Third Quarter Financial Results on Thursday, November 6, 2008 Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQ's Minimum Bid Price Rule

(Date:11/4/2009)...ct. 26 BIO-key Internati... finger-based biometric identification software is...t the AABB TXPO conference being held at the New O...BIO-key will provide hands-on product demonstratio...gy in booth #424. Also, at 5 PM on Monday, October...

(Date:11/4/2009)...if., Nov. 4 GenVault Corporation (...M.D., Ph.D., has joined its Board of Directors. D...he Salk Institute, is an acclaimed physician-scien...Salk Institute, Dr. Brody served as president of T...e National Academy of Engineering and the Institut...

(Date:11/3/2009)...FL (November 4, 2009) For more than 25 years, all... ( Strombus gigas ) have been unsuccessfuluntil no...ng techniques to produce beaded (nucleated) and no... been developed by scientists from Florida Atlanti...te (HBOI). With less than two years of research an...

Breaking Biology News(10 mins):BIO-key(R) International Exhibiting at AABB TXPO 2 Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2 Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3 Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 2 Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 3 iLife Americas LLC Enters U S Wellness and Therapeutic Markets 14561 1 iLife Americas LLC Enters U S Wellness and Therapeutic Markets 14561 2 Henry Schein to Webcast Third Quarter 2009 Conference Call Wednesday November 4 at 10 A M EST 59891 1 Henry Schein to Webcast Third Quarter 2009 Conference Call Wednesday November 4 at 10 A M EST 59891 2 SemBioSys provides an update on Botaneco 14559 1 SemBioSys provides an update on Botaneco 14559 2 SemBioSys provides an update on Botaneco 14559 3 SemBioSys provides an update on Botaneco 14559 4

[0] BIO-key(R) International Exhibiting at AABB TXPO [0] Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors [0] Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch

...e pet animal, are attractive to owners because of ...re to parrots than what meets the eye. , For more...ts use an unusual set of pigments to produce their...identity has remained elusive. Now, an Arizona Sta...ry behind the colors of parrots, describing on a m...

...Children,s Research,Hospital have discovered that ... bacteria helps these germs invade the human blood...the EMBO Journal, could help,scientists develop a ...otecting children against the disease. The St. Jud...dle-like molecule that,Streptococcus pneumoniae ba...

...l geneticists have found links in the cell death m... for studying and targeting a process vital to dev...iseases. , The work, reported in the February 17 ...dria, the cellular power plant, in prompting worm ...eath models along the evolutionary spectrum, from ...

Other Biology News:ASU researchers finds novel chemistry at work to provide parrot's vibrant red colors 2 ASU researchers finds novel chemistry at work to provide parrot's vibrant red colors 3 New comparative toxicogenomics database 2 New comparative toxicogenomics database 3 Critical role in programmed cell death identified 2 Critical role in programmed cell death identified 3

ASU researchers finds novel chemistry at work to provide parrot's vibrant red colors New comparative toxicogenomics database Critical role in programmed cell death identified

A431 cells stimulated with EGF from Exalpha Biologicals, Inc.

...ws graphic manipulation of DNA sequences and sophi...winning interface design that allows graphic manip...sophisticated drawing capabilities for Mac and Win...g Software" by the Biotechnology Software and Inte...

...lances and scales with RS232 ports and sends that ...can type the weight into the program, BalanceTalk ...o use parser extracts required data , Add date/tim...data at timed intervals , Keyboard macros automate...

SlideHyb™ Glass Array Hybridization Survey Kit from Ambion

Biology Products:

A431 cells stimulated with EGF from Exalpha Biologicals, Inc.Gene Construction Kit™ 2.5 from Textco, Inc.BalanceTalk from Labtronics, Inc.SlideHyb™ Glass Array Hybridization Survey Kit from Ambion

( y upon if a business can be certain tha...)Early Stage 10: The nuances of federal laws